Track topics on Twitter Track topics that are important to you
Pfizer Inc. (NYSE: PFE) today announced that detailed results from two pivotal Phase 3 studies of TRUMENBA® (Meningococcal Group B Vaccine) were published in the New England Journal of Medicine (NEJM). Data from both studies demonstrated that TRUMENBA, as a three-dose series, elicits a protective immune response against diverse meningococcal group B (Men...
Here's what we chose for you from NEJM Group today: New England Journal of Medicine: Perspective: A physician and researcher makes the case that sexual...
This study is the first evidence that neither insecticides nor vaccines were culprits in the alarming number of babies born with microcephaly.
The French executive made the public apology after he was castigated by SAGIP Rep. Rodante Marcoleta for his company’s “insensitivity” to the concerns of the Filipino public.
Zoetis today announced the launch of Vanguard® CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against two strains of the virus known to be circulating in the U.S., CIV H3N2 and CIV H3N8. CIV is a severe and highly contagious respiratory infection that has caused many...
High-dose cholera vaccine developed by UMSOM scientists shows promise for controlling outbreaks
The drugmaker held an “innovation day” to discuss its pipeline of new drugs while it attempts to overcome fallout from a safety row in the Philippines over its dengue vaccine.
Flu shot could still keep you out of the hospital -- or the morgue.
Just under half of health care workers do not get their annual flu vaccine. Some of these workers contract the flu and unknowingly transfer it to their sick hospitalized patients, and in some cases, because of them passing the flu along, those patients die. We know the most important reason for health care workers to […]
Avondale Pharmaceuticals raised the price of Niacor, a prescription version of Niacin, by 809 percent last month.
Takes Control of Full U.S. Marketing and Distribution Rights to IXIARO® Vaccine for Protection Against Japanese Encephalitis Valneva SE, a fully integrated commercial stage biotech company focused on developing innovative, lifesaving vaccines, today announced that its subsidiary Intercell USA, Inc. has formally changed its name to Valneva USA, Inc. (V...
Sanofi's vaccine worsens, rather than prevents, future dengue infections in some patients. The company vaccinated 830,000 children in the Philippines, where lawmakers now demand an accounting.
Proceeds will be used to progress lead development programs through Proof-of-Concept clinical trials Vienna, Austria, 11 December 2017 - Hookipa Biotech AG (“Hookipa”), a clinical stage biotech company pioneering an innovative class of immune activation therapies for oncology and infectious diseases, today announced that it has raised $59.6 million (€50.0 million) in an overs...
Proceeds will be used to progress lead development programs through Proof-of-Concept clinical trials Hookipa Biotech AG (“Hookipa”), a clinical stage biotech company pioneering an innovative class of immune activation therapies for oncology and infectious diseases, today announced that it has raised $59.6 million (€50.0 million) in an over...
SummaryPanProvincial Vaccine Enterprise Inc PREVENT is a national vaccine commercialization consortium that specializes in research and development of vaccines for infectious diseases. The institute develops vaccines for infectious disease, group A streptococcus vaccine, chlamydia vaccine, influenzaPAL vaccine, RSVP3 vaccine and CWD vaccine. It discovers vaccine through preclinical to Phase l and ...
In this Friday, Sept. 22, 2017 file photo, a flu vaccine injection is administered at the Brownsville Events Center by a pharmacist in Brownsville, Texas.
Michael JohnsenRite Aid is offering three types of flu vaccines: a quadrivalent flu vaccine which offers protection against four strains of the flu; the standard trivalent vaccine; and FLUAD, a trivalent vaccine. read more
NewsThe Philippine government will demand a $69.5 million refund from Sanofi Pasteur and look at possible legal action after a study showed the vaccine used in a dengue immunization program could expose some people to severe illness.
NewsThree people died during the outbreak in eastern Uganda near the Kenya border. There is no drug or vaccine for Marburg, which belongs to the same family as Ebola.
Generex to receive a $700,000 USD up-front license fee; deal includes milestone payments and royalties Generex Biotechnology Corporation (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) (